{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:04:39Z","timestamp":1789578279586,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006196","name":"Oulun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020019","name":"Biocenter, University of Oulu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["TK SA356920"],"award-info":[{"award-number":["TK SA356920"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.redox.2026.104206","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:47:15Z","timestamp":1778762835000},"page":"104206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinically approved HIF-PHIs modulate redox metabolism, cell growth, and angiogenesis independent of HIF-1\u03b1\/HIF-2\u03b1"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-3009","authenticated-orcid":false,"given":"Daniela","family":"Mennerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi","family":"Khoder-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Beter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elitsa Y.","family":"Dimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kietzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104206_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100677","article-title":"Iron-Deficiency anemia in CKD: a narrative review for the kidney care team","volume":"5","author":"Hain","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.redox.2026.104206_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.yexcr.2012.02.035","article-title":"Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents","volume":"318","author":"Tanaka","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.redox.2026.104206_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: first global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2026.104206_bib4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2026.104206_bib5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40265-020-01383-z","article-title":"Vadadustat: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2026.104206_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40265-020-01444-3","article-title":"Enarodustat: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2026.104206_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104206_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2026.104206_bib10","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104206_bib11","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1","volume":"271","author":"Jiang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib12","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104206_bib13","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third \u03b1- class hypoxia inducible factor subunit, HIF3\u03b1","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expr."},{"key":"10.1016\/j.redox.2026.104206_bib14","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-011-0679-5","article-title":"Roles of the human hypoxia-inducible factor (HIF)-3\u03b1 variants in the hypoxia response","volume":"68","author":"Heikkil\u00e4","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2026.104206_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2026.104206_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.redox.2026.104206_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.molmed.2018.10.004","article-title":"Hypoxia-inducible factor prolyl 4-Hydroxylases and metabolism","volume":"24","author":"Koivunen","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.redox.2026.104206_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104206_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104206_bib20","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.1074\/jbc.M406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoffl","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib21","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1096\/fj.04-1640fje","article-title":"Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and kelly cells","volume":"18","author":"Warnecke","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2026.104206_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.redox.2026.104206_bib23","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.270.22.13333","article-title":"Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia","volume":"270","author":"Levy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib24","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104206_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yexcr.2017.03.013","article-title":"Regulation of hypoxia-inducible gene expression after HIF activation","volume":"356","author":"Suzuki","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.redox.2026.104206_bib26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41589-018-0137-x","article-title":"New tricks for an old drug","volume":"14","author":"Nelson","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2026.104206_bib27","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1039\/C7SC02103H","article-title":"Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials","volume":"8","author":"Yeh","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.redox.2026.104206_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biochem-061516-044724","article-title":"2-Oxoglutarate-Dependent oxygenases","volume":"87","author":"Islam","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.redox.2026.104206_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01578-2","article-title":"Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis","volume":"8","author":"Yan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104206_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13706","article-title":"Get use to the -dustats: roxadustat and molidustat, members of the hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor drug class promote kidney function, perfusion and oxygenation in rats through nitric oxide","volume":"233","author":"Jensen","year":"2021","journal-title":"Acta Physiol."},{"key":"10.1016\/j.redox.2026.104206_bib31","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/cmdc.202100133","article-title":"Structural basis of prolyl hydroxylase domain inhibition by molidustat","volume":"16","author":"Figg","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.redox.2026.104206_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.isci.2019.02.027","article-title":"The circadian clock protein CRY1 is a negative regulator of HIF-1\u03b1","volume":"13","author":"Dimova","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.redox.2026.104206_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.celrep.2015.03.012","article-title":"NF-\u03baB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer","volume":"11","author":"Blakely","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2026.104206_bib34","article-title":"HIF-1-Independent mechanisms regulating metabolic adaptation in hypoxic cancer cells","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104206_bib35","doi-asserted-by":"crossref","first-page":"48983","DOI":"10.18632\/oncotarget.16904","article-title":"Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells","volume":"8","author":"Thor\u00e9n","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2026.104206_bib36","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/cdd.2008.84","article-title":"Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L","volume":"15","author":"Papandreou","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2026.104206_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104206_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10157-021-02070-3","article-title":"Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects","volume":"25","author":"Nagano","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.redox.2026.104206_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae051","article-title":"Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia","volume":"17","author":"Nakanishi","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.redox.2026.104206_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.kisu.2020.12.002","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease","volume":"11","author":"Haase","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.redox.2026.104206_bib41","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1021\/acs.jmedchem.5c00586","article-title":"Derivatives of the clinically used HIF prolyl hydroxylase inhibitor desidustat are efficient inhibitors of human \u03b3-Butyrobetaine hydroxylase","volume":"68","author":"Corner","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cpdd.597","article-title":"Evaluation of food and spherical carbon adsorbent effects on the pharmacokinetics of roxadustat in healthy nonelderly adult Male Japanese subjects","volume":"8","author":"Shibata","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.redox.2026.104206_bib43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/cmdc.201700783","article-title":"Discovery of molidustat (BAY 85-3934): a small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia","volume":"13","author":"Beck","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.redox.2026.104206_bib44","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/bcp.13584","article-title":"First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia","volume":"84","author":"B\u00f6ttcher","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.redox.2026.104206_bib45","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/cc.10.8.15326","article-title":"HIF-1\u03b1 depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs","volume":"10","author":"Culver","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.redox.2026.104206_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/febs.70440","article-title":"Rethinking the role of HIF in hepatocellular carcinoma","author":"Kenneth","year":"2026","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2026.104206_bib47","article-title":"Oxygen-independent expression of HIF-1\u03b1 during the cell cycle in hepatocellular carcinoma cells controls essential metabolic pathways under normoxia","author":"Gkotinakou","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2026.104206_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05361-6","article-title":"Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress","volume":"81","author":"Jacquemin","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2026.104206_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05304-8","article-title":"HIF-\u03b1 activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis","volume":"13","author":"Su","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104206_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05532-y","article-title":"Correction: HIF-\u03b1 activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis","volume":"14","author":"Su","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104206_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-04993-3","article-title":"Inhibition of OGFOD1 by FG4592 confers neuroprotection by activating unfolded protein response and autophagy after ischemic stroke","volume":"22","author":"Xie","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.redox.2026.104206_bib52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ajh.26865","article-title":"Open-label, phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies","volume":"98","author":"Glaspy","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.redox.2026.104206_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.23.02742","article-title":"Efficacy and safety of roxadustat for anemia in patients receiving chemotherapy for nonmyeloid malignancies: a randomized, open-label, active-controlled phase III study","volume":"43","author":"Lu","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104206_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","article-title":"HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity","volume":"11","author":"Zhang","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104206_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104206_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102649","article-title":"Ferroptosis as a therapeutic target in glioblastoma: mechanisms and emerging strategies","volume":"36","author":"Mashayekhi","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.redox.2026.104206_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.redox.2026.104206_bib58","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood-2007-06-094441","article-title":"Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor","volume":"110","author":"K\u00f6ditz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.redox.2026.104206_bib59","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41589-025-01887-3","article-title":"PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation","volume":"21","author":"Zheng","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2026.104206_bib60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46490","article-title":"Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates","volume":"8","author":"Cockman","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.redox.2026.104206_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.108128.3","article-title":"Systematic characterization of site-specific proline hydroxylation using hydrophilic interaction chromatography and mass spectrometry","volume":"14","author":"Jiang","year":"2026","journal-title":"eLife"},{"key":"10.1016\/j.redox.2026.104206_bib62","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1074\/jbc.M111.299180","article-title":"Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia","volume":"287","author":"Romero-Ruiz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib63","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1073\/pnas.1311750111","article-title":"Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy","volume":"111","author":"Loenarz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104206_bib64","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1073\/pnas.1314482111","article-title":"OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation","volume":"111","author":"Singleton","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104206_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105086","article-title":"Chemical inhibition of oxygen-sensing prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming","volume":"25","author":"Tiwari","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.redox.2026.104206_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06893-9","article-title":"Collagen prolyl 4-hydroxylase 1 is essential for HIF-1\u03b1 stabilization and TNBC chemoresistance","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104206_bib67","article-title":"Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials","volume":"17","author":"Minutolo","year":"2023","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.redox.2026.104206_bib68","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/ndt\/gfab191","article-title":"Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, open-label, active-controlled study (DOLOMITES)","volume":"36","author":"Barratt","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.redox.2026.104206_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/ndt\/gfab349","article-title":"Erratum to: roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomised, open-label, active-controlled study (DOLOMITES)","volume":"37","author":"Barratt","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.redox.2026.104206_bib70","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"issue":"Pt 1","key":"10.1016\/j.redox.2026.104206_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/bj3340141","article-title":"Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element\/activator protein-1 element in primary cultures of rat hepatocytes","volume":"334","author":"Immenschuh","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2026.104206_bib72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004060170037","article-title":"Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death","volume":"251","author":"Kietzmann","year":"2001","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.redox.2026.104206_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/BC.2004.018","article-title":"Modulation of glucokinase expression by hypoxia-inducible factor 1 and upstream stimulatory factor 2 in primary rat hepatocytes","volume":"385","author":"Roth","year":"2004","journal-title":"Biol. Chem."},{"key":"10.1016\/j.redox.2026.104206_bib74","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2026.104206_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0076-6879(08)02004-1","article-title":"An optimized three-dimensional in vitro model for the analysis of angiogenesis","volume":"443","author":"Nakatsu","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.redox.2026.104206_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33090-6","article-title":"SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space","volume":"13","author":"Beter","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104206_bib77","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:13:05Z","timestamp":1783167185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"alternative-id":["S2213231726002041"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104206","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8582402\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-8582402\/v2","asserted-by":"object"}]},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically approved HIF-PHIs modulate redox metabolism, cell growth, and angiogenesis independent of HIF-1\u03b1\/HIF-2\u03b1","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104206"}}